![](/img/cover-not-exists.png)
The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment
Manuel Lima-Rodrigues, Nuno Lamas, Ana Valle-Fernandes, Andrea Cruz, Artur Vieira, Pedro Oliveira, Jorge Pedrosa, António G. Castro, Rui M. Reis, Fátima Baltazar, Armando AlmeidaVolume:
59
Language:
english
Pages:
11
DOI:
10.1007/s00011-010-0185-5
Date:
September, 2010
File:
PDF, 1.90 MB
english, 2010